Catalyst Pharma: Are the Risks Worth the Potential Rewards?
The company has strong prospects but an uncertain future.
Catalyst Pharmaceuticals
CPRX
CPRX
$5.24
-$0.06
-1.0%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive CPRX Charts
A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.
News & Analysis: Catalyst Pharmaceuticals
3 Top Small-Cap Stocks to Buy in October
These small-cap healthcare stocks are definitely worth checking out this month.
Catalyst Pharmaceuticals: Nothing Has Changed
Here's why Catalyst's shareholder might want to simply shrug off yesterday's downturn.
Why Catalyst Pharmaceuticals Stock Is Tumbling Today
Catalyst's latest bout of volatility could be a great buying opportunity for risk-tolerant investors.
3 Top Biotech Stocks to Buy in September
These three biotech stocks could be great buys this month.
Why Catalyst Pharmaceuticals Stock Is Sinking Today
Shares drop after management announces a surprise capital raise. Here's what investors need to know.
Catalyst Pharmaceuticals Inc (CPRX) Q2 2019 Earnings Call Transcript
CPRX earnings call for the period ending June 30, 2019.
Why Catalyst Pharmaceuticals Stock Broke Down Today
Catalyst's shares took a sizable hit this morning.
2 Small-Cap Stocks That Could Make You Rich
The small-cap healthcare stocks Catalyst Pharmaceuticals and MedMen Enterprises have enormous upside potential.
2 Top Stocks to Buy in August
Adverum Biotechnologies and Catalyst Pharmaceuticals could both post sizable gains next month.
